© 1997 American Heart Association, Inc.
Articles |
Na+-H+ Exchange Inhibition Protects Against Mechanical, Ultrastructural, and Biochemical Impairment Induced by Low Concentrations of Lysophosphatidylcholine in Isolated Rat Hearts
the Department of Pharmacology & Toxicology, Faculty of Medicine, University of Western Ontario, London, Canada.
Correspondence to Dr M. Karmazyn, Department of Pharmacology and Toxicology, University of Western Ontario, Medical Sciences Building, London, Ontario N6A 5C1, Canada. E-mail mkarm@julian.uwo.ca
Lysophophatidylcholine (LysoPC) accumulates rapidly in the ischemic myocardium and is an important mediator of ischemia-induced cell injury. Na+-H+ exchange (NHE) inhibition has been demonstrated to protect the ischemic and reperfused myocardium. We determined whether NHE inhibition can also modulate cardiotoxicity produced by LysoPC (3 and 5 µmol/L) in isolated rat hearts. At 3 µmol/L, LysoPC produced a depression in left ventricular developed pressure (LVDP) and elevation in left ventricular end-diastolic pressure (LVEDP), which were 19±7% and 1290±205% of pre-LysoPC values, respectively, after 30 minutes of treatment. In the presence of the NHE inhibitor 4-isopropyl-3-methylsulfonylbenzoyl-guanidine methanesulfonate (HOE 642, 5 µmol/L), LVDP was reduced to only 80.8±8.6%, and LVEDP increased to 270±32% (P<.05 for both parameters). LysoPC significantly depressed tissue ATP, creatine phosphate, and glycogen contents and increased lactate levels, all of which were significantly attenuated by HOE 642. Moreover, marked LysoPC-induced ultrastructural abnormalities, including mitochondrial and myofibrillar disruption, were totally prevented by HOE 642. This protection was mimicked by another NHE inhibitor, methylisobutylamiloride (5 µmol/L). HOE 642 was also effective against injury produced by 5 µmol/L LysoPC although, generally, the protection was less marked than that observed against 3 µmol/L; LVDP depression after 30 minutes was 10.1±4.3% and 41.4±10.4% of pre-LysoPC values in control and HOE 642-treated hearts, respectively (P<.05), whereas corresponding LVEDP elevations were 1629±393% and 990±144% (P>.05). In myocytes superfused with bicarbonate-free buffer subjected to acid loading by NH4Cl pulsing, pH recovery (as measured by acid flux) was significantly stimulated by 3 µmol/L LysoPC, indicative of NHE activation. Our study shows that cardiac injury produced by low concentrations of LysoPC can be effectively attenuated by NHE inhibition. The results also suggest that the beneficial effects of NHE inhibitors on the ischemic myocardium may be, at least partially, mediated by inhibiting the deleterious effects of LysoPC.
Key Words: lysophosphatidylcholine • isolated rat heart • myocyte • cardiac injury • Na+-H+ exchange
This article has been cited by other articles:
 |
|
 |
|
  J. S. Corvera, Z.-Q. Zhao, L. S. Schmarkey, S. L. Katzmark, J. M. Budde, C. D. Morris, T. Ehring, R. A. Guyton, and J. Vinten-Johansen Optimal dose and mode of delivery of Na+/H+ exchange-1 inhibitor are critical for reducing postsurgical ischemia-reperfusion injury Ann. Thorac. Surg., November 1, 2003; 76(5): 1614 - 1622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Mentzer Jr, R. D. Lasley, A. Jessel, and M. Karmazyn Intracellular sodium hydrogen exchange inhibition and clinical myocardial protection Ann. Thorac. Surg., February 1, 2003; 75(2): S700 - 708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Gazmuri, I. M. Ayoub, E. Hoffner, and J. D. Kolarova Successful Ventricular Defibrillation by the Selective Sodium-Hydrogen Exchanger Isoform-1 Inhibitor Cariporide Circulation, July 10, 2001; 104(2): 234 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-P. Cheng, T. Ukai, K. Onishi, N. Ohte, M. Suzuki, Z.-S. Zhang, H.-J. Cheng, H. Tachibana, A. Igawa, and W. C. Little The role of ANG II and endothelin-1 in exercise-induced diastolic dysfunction in heart failure Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1853 - H1860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Karmazyn, X. T. Gan, R. A Humphreys, H. Yoshida, and K. Kusumoto The Myocardial Na+-H+ Exchange : Structure, Regulation, and Its Role in Heart Disease Circ. Res., October 29, 1999; 85(9): 777 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Golfman, N. J. Haughey, J. T. Wong, J. Y. Jiang, D. Lee, J. D. Geiger, and P. C. Choy Lysophosphatidylcholine induces arachidonic acid release and calcium overload in cardiac myoblastic H9c2 cells J. Lipid Res., October 1, 1999; 40(10): 1818 - 1826. [Abstract] [Full Text]
|
|
|
|
|
|
X. T. Gan, S. Chakrabarti, and M. Karmazyn Modulation of Na+/H+ exchange isoform 1 mRNA expression in isolated rat hearts Am J Physiol Heart Circ Physiol, September 1, 1999; 277(3): H993 - H998. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Wilson, J. B. Waldrip, K. H. Nielson, A. M. Judd, S. K. Han, W. Cho, P. J. Sims, and J. D. Bell Mechanisms by Which Elevated Intracellular Calcium Induces S49 Cell Membranes to Become Susceptible to the Action of Secretory Phospholipase A2 J. Biol. Chem., April 23, 1999; 274(17): 11494 - 11504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Humphreys, J. V. Haist, S. Chakrabarti, Q. Feng, J. M. O. Arnold, and M. Karmazyn Orally administered NHE1 inhibitor cariporide reduces acute responses to coronary occlusion and reperfusion Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H749 - H757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chen, C.-Y. Xiao, H. Hashizume, and Y. Abiko Phospholipase A2 is not responsible for lysophosphatidylcholine-induced damage in cardiomyocytes Am J Physiol Heart Circ Physiol, November 1, 1998; 275(5): H1782 - H1787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Myers, P. Farhangkhoee, and M. Karmazyn Hydrogen peroxide induced impairment of post-ischemic ventricular function is prevented by the sodium-hydrogen exchange inhibitor HOE 642 (cariporide) Cardiovasc Res, November 1, 1998; 40(2): 290 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Yu, T. Netticadan, Y.-J. Xu, V. Panagia, and N. S. Dhalla Mechanisms of Lysophosphatidylcholine-Induced Increase in Intracellular Calcium in Rat Cardiomyocytes J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 1 - 8. [Abstract] [Full Text]
|
|
|
|
|
|
O. Frohlich and M. Karmazyn The Na-H exchanger revisited: an update on Na-H exchange regulation and the role of the exchanger in hypertension and cardiac function in health and disease Cardiovasc Res, November 1, 1997; 36(2): 138 - 148. [Full Text] [PDF]
|
|